642 related articles for article (PubMed ID: 27724869)
1. Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non- culprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT-FFR) prospective study. Rationale and design.
Kennedy MW; Fabris E; Ijsselmuiden AJ; Nef H; Reith S; Escaned J; Alfonso F; van Royen N; Wojakowski W; Witkowski A; Indolfi C; Ottervanger JP; Suryapranata H; Kedhi E
Cardiovasc Diabetol; 2016 Oct; 15(1):144. PubMed ID: 27724869
[TBL] [Abstract][Full Text] [Related]
2. Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial.
Kedhi E; Berta B; Roleder T; Hermanides RS; Fabris E; IJsselmuiden AJJ; Kauer F; Alfonso F; von Birgelen C; Escaned J; Camaro C; Kennedy MW; Pereira B; Magro M; Nef H; Reith S; Al Nooryani A; Rivero F; Malinowski K; De Luca G; Garcia Garcia H; Granada JF; Wojakowski W
Eur Heart J; 2021 Dec; 42(45):4671-4679. PubMed ID: 34345911
[TBL] [Abstract][Full Text] [Related]
3. Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights From the COMBINE OCT-FFR Trial.
Fabris E; Berta B; Roleder T; Hermanides RS; IJsselmuiden AJJ; Kauer F; Alfonso F; von Birgelen C; Escaned J; Camaro C; Kennedy MW; Pereira B; Magro M; Nef H; Reith S; Roleder-Dylewska M; Gasior P; Malinowski K; De Luca G; Garcia-Garcia HM; Granada JF; Wojakowski W; Kedhi E
Circ Cardiovasc Interv; 2022 May; 15(5):e011728. PubMed ID: 35485232
[TBL] [Abstract][Full Text] [Related]
4. Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial.
Roleder-Dylewska M; Gasior P; Hommels TM; Roleder T; Berta B; Ang HY; Ng JCK; Hermanides RS; Fabris E; IJsselmuiden AJJ; Kauer F; Alfonso F; von Birgelen C; Escaned J; Camaro C; Kennedy MW; Pereira B; Magro M; Nef H; Reith S; Malinowski K; De Luca G; Garcia Garcia HM; Granada JF; Wojakowski W; Kedhi E
Eur Heart J Cardiovasc Imaging; 2023 Apr; 24(5):687-693. PubMed ID: 36342269
[TBL] [Abstract][Full Text] [Related]
5. Correlation between optical coherence tomography-derived intraluminal parameters and fractional flow reserve measurements in intermediate grade coronary lesions: a comparison between diabetic and non-diabetic patients.
Reith S; Battermann S; Hellmich M; Marx N; Burgmaier M
Clin Res Cardiol; 2015 Jan; 104(1):59-70. PubMed ID: 25124054
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography-defined plaque vulnerability in relation to functional stenosis severity stratified by fractional flow reserve and quantitative flow ratio.
Kanno Y; Sugiyama T; Hoshino M; Usui E; Hamaya R; Kanaji Y; Murai T; Lee T; Yonetsu T; Kakuta T
Catheter Cardiovasc Interv; 2020 Sep; 96(3):E238-E247. PubMed ID: 32012438
[TBL] [Abstract][Full Text] [Related]
7. Three-Year Clinical Impact of Murray Law-Based Quantitative Flow Ratio and OCT- or FFR-Guidance in Angiographically Intermediate Coronary Lesions.
Aurigemma C; Ding D; Tu S; Li C; Yu W; Li Y; Leone AM; Romagnoli E; Vergallo R; Maino A; Trani C; Wijns W; Burzotta F
Circ Cardiovasc Interv; 2024 May; 17(5):e013191. PubMed ID: 38660794
[TBL] [Abstract][Full Text] [Related]
8. Vulnerable plaque features and adverse events in patients with diabetes mellitus: a post hoc analysis of the COMBINE OCT-FFR trial.
Del Val D; Berta B; Roleder T; Malinowski K; Bastante T; Hermanides RS; Wojakowski W; Fabris E; Cuesta J; De Luca G; Rivero F; Alfonso F; Kedhi E
EuroIntervention; 2024 Jun; 20(11):e707-e717. PubMed ID: 38840580
[TBL] [Abstract][Full Text] [Related]
9. Fractional Flow Reserve or Optical Coherence Tomography to Guide Management of Angiographically Intermediate Coronary Stenosis: A Single-Center Trial.
Burzotta F; Leone AM; Aurigemma C; Zambrano A; Zimbardo G; Arioti M; Vergallo R; De Maria GL; Cerracchio E; Romagnoli E; Trani C; Crea F
JACC Cardiovasc Interv; 2020 Jan; 13(1):49-58. PubMed ID: 31918942
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma.
Fabris E; Berta B; Hommels T; Roleder T; Hermanides RS; Rivero F; von Birgelen C; Escaned J; Camaro C; Kennedy MW; Pereira B; Magro M; Nef H; Reith S; Roleder-Dylewska M; Gasior P; Malinowski KP; De Luca G; Garcia-Garcia HM; Granada JF; Wojakowski W; Kedhi E
EuroIntervention; 2023 Feb; 18(13):e1099-e1107. PubMed ID: 36170036
[TBL] [Abstract][Full Text] [Related]
11. Lesion-Specific and Vessel-Related Determinants of Fractional Flow Reserve Beyond Coronary Artery Stenosis.
Ahmadi A; Leipsic J; Øvrehus KA; Gaur S; Bagiella E; Ko B; Dey D; LaRocca G; Jensen JM; Bøtker HE; Achenbach S; De Bruyne B; Nørgaard BL; Narula J
JACC Cardiovasc Imaging; 2018 Apr; 11(4):521-530. PubMed ID: 29311033
[TBL] [Abstract][Full Text] [Related]
12. Prospective Randomized Comparison of Fractional Flow Reserve Versus Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses: One-Month Results.
Leone AM; Burzotta F; Aurigemma C; De Maria GL; Zambrano A; Zimbardo G; Arioti M; Cerracchio E; Vergallo R; Trani C; Crea F
J Am Heart Assoc; 2019 Aug; 8(15):e012772. PubMed ID: 31331219
[TBL] [Abstract][Full Text] [Related]
13. CT-based total vessel plaque analyses improves prediction of hemodynamic significance lesions as assessed by fractional flow reserve in patients with stable angina pectoris.
Øvrehus KA; Gaur S; Leipsic J; Jensen JM; Dey D; Bøtker HE; Ahmadi A; Achenbach S; Ko B; Nørgaard BL
J Cardiovasc Comput Tomogr; 2018; 12(4):344-349. PubMed ID: 29866619
[TBL] [Abstract][Full Text] [Related]
14. Relationship between optical coherence tomography derived intraluminal and intramural criteria and haemodynamic relevance as determined by fractional flow reserve in intermediate coronary stenoses of patients with type 2 diabetes.
Reith S; Battermann S; Jaskolka A; Lehmacher W; Hoffmann R; Marx N; Burgmaier M
Heart; 2013 May; 99(10):700-7. PubMed ID: 23543283
[TBL] [Abstract][Full Text] [Related]
15. Impact of type 2 diabetes mellitus and glucose control on fractional flow reserve measurements in intermediate grade coronary lesions.
Reith S; Battermann S; Hellmich M; Marx N; Burgmaier M
Clin Res Cardiol; 2014 Mar; 103(3):191-201. PubMed ID: 24264473
[TBL] [Abstract][Full Text] [Related]
16. Optical Coherence Tomography-Defined Plaque Vulnerability in Relation to Functional Stenosis Severity and Microvascular Dysfunction.
Usui E; Yonetsu T; Kanaji Y; Hoshino M; Yamaguchi M; Hada M; Fukuda T; Sumino Y; Ohya H; Hamaya R; Kanno Y; Yuki H; Murai T; Lee T; Hirao K; Kakuta T
JACC Cardiovasc Interv; 2018 Oct; 11(20):2058-2068. PubMed ID: 30336810
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Deferred Lesions With Angiographically Insignificant Stenosis But Low Fractional Flow Reserve.
Lee JM; Koo BK; Shin ES; Nam CW; Doh JH; Hu X; Ye F; Chen S; Yang J; Chen J; Tanaka N; Yokoi H; Matsuo H; Takashima H; Shiono Y; Hwang D; Park J; Kim KJ; Akasaka T; Wang J
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862970
[TBL] [Abstract][Full Text] [Related]
18. Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty (FORZA) trial: study protocol for a randomized controlled trial.
Burzotta F; Leone AM; De Maria GL; Niccoli G; Coluccia V; Pirozzolo G; Saffioti S; Aurigemma C; Trani C; Crea F
Trials; 2014 Apr; 15():140. PubMed ID: 24758510
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes According to Fractional Flow Reserve or Instantaneous Wave-Free Ratio in Deferred Lesions.
Lee JM; Shin ES; Nam CW; Doh JH; Hwang D; Park J; Kim KJ; Zhang J; Ahn C; Koo BK
JACC Cardiovasc Interv; 2017 Dec; 10(24):2502-2510. PubMed ID: 29198458
[TBL] [Abstract][Full Text] [Related]
20. Correlation between fractional flow reserve and instantaneous wave-free ratio with morphometric assessment by optical coherence tomography in diabetic patients.
Rivero F; Antuña P; García-Guimaraes M; Jiménez C; Cuesta J; Bastante T; Alfonso F
Int J Cardiovasc Imaging; 2020 Jul; 36(7):1193-1201. PubMed ID: 32221772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
